Skip to main content
Caplight Logo









Capstan Medical

Capstan Medical

Private
Santa Cruz, CaliforniaHealthcare & Life Scienceshttps://capstanmedical.com/

Last Round

Series C

Dec 11, 2024

Total Funding Raised

$141.4M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Capstan Medical is a medical device company that develops robotic-enabled, minimally invasive solutions for the treatment of structural heart disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Industrial Robotics, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

structural heart roboticsrobotic catheterminimally invasive surgerysurgical roboticsheart valve replacementmedtechrobotic surgeryinterventional cardiologycatheter-based interventionmedical device manufacturerrobotic platformmitral valve replacementsurgical automationAI enhanced imagingdigital surgery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Capstan Medical Comparables

Compare Capstan Medical with similar companies based on industry and business-model similarity.

Capstan Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Remedy Robotics
78%
Siemens Healthineers
73%
Tioga Cardiovascular
73%

Capstan Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CDec 11, 2024
Series BAug 9, 2023

Key People

Founding team and executive leadership

Dan Wallace

Founder CTO At Capstan Medical

Founding Team

Maggie Nixon

CEO - Capstan Medical

Executive Team

Capstan Medical Investors

Notable investors and investment history

Capstan Medical investors
InvestorRounds
Puma Venture CapitalSeries B
Eclipse VenturesSeries C, Series B
Intuitive VenturesSeries C, Series B
Gideon Strategic PartnersSeries C
Yu GalaxySeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Grew 15% QoQ, from 84 to 97 employees.

  • Apr 27, 2026

    Will use Clario for patient screening in clinical studies.

Capstan Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Capstan Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Capstan Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersSanta Cruz, California
Employee Range97
Year Founded2020
Last FundingDec 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?